| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.092 | 600 | 0 | 0 | 527 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.092 | 600 | 0 | 0 | 527 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.875 | 1.710 | 33 | 32 | 1.370 | 41 | 30 | 0 | 30 | 40 |
| Gross Profit/Loss - EUR | -1.783 | -1.110 | -33 | -32 | -843 | -41 | -30 | 0 | -30 | -40 |
| Net Profit/Loss - EUR | -1.876 | -1.126 | -33 | -32 | -859 | -41 | -30 | 0 | -30 | -40 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Criselioma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.527 | 1.404 | 1.380 | 1.354 | 0 | 0 | 0 | 0 | 172 | 131 |
| Inventories | 1.508 | 1.403 | 1.380 | 1.354 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 172 | 131 |
| Shareholders Funds | -5.100 | -6.174 | -6.103 | -6.023 | -6.765 | -6.678 | -6.561 | -6.581 | -6.591 | -6.595 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.627 | 7.578 | 7.482 | 7.377 | 6.765 | 6.678 | 6.561 | 6.581 | 6.763 | 6.725 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Criselioma Srl